Rhumbline Advisers Travere Therapeutics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 118,608 shares of TVTX stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,608

Previous 125,660 5.61%

Holding current value

$2.12 Million

Previous $1.03 Million 60.76%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$7.89 - $15.21 $55,640 - $107,260	-7,052 Reduced 5.61%	118,608 $1.66 Million
Q2 2024 Aug 01, 2024	BUY	$5.26 - $8.28 $98,072 - $154,380	18,645 Added 17.42%	125,660 $1.03 Million
Q1 2024 May 09, 2024	SELL	$7.18 - $9.82 $8,766 - $11,990	-1,221 Reduced 1.13%	107,015 $825,000
Q4 2023 Feb 08, 2024	SELL	$5.44 - $9.5 $26,237 - $45,818	-4,823 Reduced 4.27%	108,236 $973,000
Q3 2023 Nov 09, 2023	SELL	$7.64 - $17.25 $2,933 - $6,624	-384 Reduced 0.34%	113,059 $1.01 Million
Q2 2023 Aug 08, 2023	BUY	$15.3 - $22.61 $237,792 - $351,404	15,542 Added 15.88%	113,443 $1.74 Million
Q1 2023 May 11, 2023	BUY	$17.82 - $22.89 $4,722 - $6,065	265 Added 0.27%	97,901 $2.2 Million
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $58,254 - $82,445	3,154 Added 3.34%	97,636 $2.05 Million
Q3 2022 Nov 10, 2022	BUY	$22.91 - $28.63 $158,674 - $198,291	6,926 Added 7.91%	94,482 $2.33 Million
Q2 2022 Aug 11, 2022	SELL	$20.94 - $30.01 $66,903 - $95,881	-3,195 Reduced 3.52%	87,556 $2.12 Million
Q1 2022 May 12, 2022	SELL	$23.61 - $30.6 $165,718 - $214,781	-7,019 Reduced 7.18%	90,751 $2.34 Million
Q4 2021 Feb 10, 2022	BUY	$24.34 - $31.17 $12,875 - $16,488	529 Added 0.54%	97,770 $3.04 Million
Q3 2021 Nov 12, 2021	BUY	$12.98 - $25.03 $39,056 - $75,315	3,009 Added 3.19%	97,241 $2.36 Million
Q2 2021 Aug 05, 2021	BUY	$14.11 - $26.4 $360,693 - $674,863	25,563 Added 37.23%	94,232 $1.38 Million
Q1 2021 May 06, 2021	SELL	$23.37 - $31.77 $56,298 - $76,533	-2,409 Reduced 3.39%	68,669 $1.72 Million
Q4 2020 Feb 10, 2021	BUY	$19.17 - $27.87 $1.36 Million - $1.98 Million	71,078 New	71,078 $1.94 Million

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.15B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Travere Therapeutics, Inc. Transaction History